Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72808 record(s)

Req # A-2024-000281

Adverse Drug Reaction (ADR) for NALTREXONE. Report number: 001083525. ADR for MIDAZOLAM. Report number: 001081539. ADRs for HEPARIN. Report numbers: 001078040, 001078077, 001080958, E2B_07052571.

Organization: Health Canada

43 page(s)
August 2024

Req # A-2024-000293

Adverse Drug Reactions (ADRs). Report numbers: 1084874, E2B_07060852, E2B_07062901, E2B_07077874, E2B_07080669, E2B_07080679, E2B_07080689.

Organization: Health Canada

85 page(s)
August 2024

Req # A-2024-000315

Adverse Drug Reaction (ADR). Report number: E2B_06906193.

Organization: Health Canada

105 page(s)
August 2024

Req # A-2024-000355

Adverse Drug Reaction (ADR). Report number: E2B_06906193.

Organization: Health Canada

105 page(s)
August 2024

Req # A-2024-000365

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-103896-539.

Organization: Health Canada

15 page(s)
August 2024

Req # A-2024-000377

Adverse Drug Reaction (ADR). Report number: E2B_06796749.

Organization: Health Canada

10 page(s)
August 2024

Req # A-2024-000474

Adverse Drug Reaction (ADR) for RIVAROXABAN. Report number: 001092189.

Organization: Health Canada

8 page(s)
August 2024

Req # A-2024-000479

Adverse Drug Reaction (ADR). Report number: 001090371.

Organization: Health Canada

1 page(s)
August 2024

Req # A-2024-000482

Adverse Drug Reaction (ADR) for CRESEMBA. Report number: 001088358.

Organization: Health Canada

3 page(s)
August 2024

Req # A-2024-000494

Adverse Drug Reaction (ADR). Report number: 001085941.

Organization: Health Canada

12 page(s)
August 2024
Date modified: